SHPH
$1.03
Market ClosedAs of Mar 17, 8:00 PM UTC
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.03
Potential Upside
5%
Whystock Fair Value$1.08
Price
UndervaluedFair ValueOvervalued
Fundamentals
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.76M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.59
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-27176.18%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.07
